Maximus (NYSE:MMS) Rating Increased to Outperform at Raymond James

Maximus (NYSE:MMS) was upgraded by equities researchers at Raymond James from a “market perform” rating to an “outperform” rating in a research note issued on Thursday, Marketbeat reports. The brokerage currently has a $90.00 price target on the health services provider’s stock. Raymond James’ price objective suggests a potential upside of 16.13% from the company’s current price.

Separately, StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, December 27th.

Maximus Price Performance

Shares of Maximus stock opened at $77.50 on Thursday. The stock has a market capitalization of $4.67 billion, a price-to-earnings ratio of 15.50 and a beta of 0.73. Maximus has a 1-year low of $69.72 and a 1-year high of $93.97. The firm’s 50-day moving average price is $77.76 and its two-hundred day moving average price is $85.27. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59.

Insider Buying and Selling at Maximus

In other Maximus news, CEO Bruce Caswell bought 3,500 shares of Maximus stock in a transaction dated Tuesday, December 17th. The shares were bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the purchase, the chief executive officer now owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now owns 6,567 shares of the company’s stock, valued at approximately $484,841.61. This represents a 25.16 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have bought 7,063 shares of company stock worth $502,017. Insiders own 1.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Central Pacific Bank Trust Division boosted its position in shares of Maximus by 39.6% during the fourth quarter. Central Pacific Bank Trust Division now owns 2,680 shares of the health services provider’s stock worth $200,000 after purchasing an additional 760 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Maximus by 8.8% during the third quarter. JPMorgan Chase & Co. now owns 223,766 shares of the health services provider’s stock worth $20,846,000 after acquiring an additional 18,143 shares in the last quarter. Tidal Investments LLC grew its stake in Maximus by 49.1% in the third quarter. Tidal Investments LLC now owns 20,674 shares of the health services provider’s stock valued at $1,926,000 after acquiring an additional 6,809 shares during the period. Wilmington Savings Fund Society FSB grew its stake in Maximus by 3.3% in the third quarter. Wilmington Savings Fund Society FSB now owns 66,805 shares of the health services provider’s stock valued at $6,224,000 after acquiring an additional 2,164 shares during the period. Finally, World Investment Advisors LLC increased its holdings in shares of Maximus by 6.6% in the third quarter. World Investment Advisors LLC now owns 5,289 shares of the health services provider’s stock worth $493,000 after acquiring an additional 326 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.